New Sheba study indicates that non-alcoholic fatty liver disease could increase the risk of COVID-19 mortality.
Israeli Advanced Ventilation Technology could help prevent ICU wards around the world from becoming overwhelmed as a result of the COVID-19 pandemic. Click here for the full story.
According to a new Sheba study, the Pfizer-BioNTech COVID-19 vaccine is highly effective: 98% saw a major increase in COVID-19 antibodies. Learn more.
Israeli PM, Benjamin Netanyahu received the first dose of the COVID-19 vaccine from Pfizer/BioNtech at Sheba Medical Center on December 19.
Sheba Medical Center team consisting of 20 medical personnel went to Northern Italy to help with the COVID-19 crisis in the Piedmont region.
Trial of the COVID-19 vaccine developed by the Israel Institute of Biological Research is set to move into Phase II within a few weeks.
Recent research conducted in Israel showed how the CRISPR-Cas9 gene editing system can be effective against metastatic cancer.
A recent partnership between Sheba and Toronto General aims to advance lung transplantation in Israel, revolutionizing how the procedure is performed.
Two more reasons to be proud of our Sheba family! Prof. Ella Mendelssohn, director at Sheba’s Virology Lab, was the first scientist to receive a sample of the coronavirus in Israel.
Proper hand hygiene is a vital part of preventing the spread of COVID-19, and an Israeli company has redesigned the sink to help people get squeaky clean.
global patient services
Global Patient Services at Sheba
CONTACT SHEBA MEDICAL CENTER
The information on this website is for general knowledge purposes only and does not constitute medical advice, diagnosis, or treatment in any form. It is not a substitute for professional medical advice from a qualified physician.
Additionally, you are browsing the official – and only – website of Sheba Medical Center and not an agent or affiliate website.